Helius Medical Technologies, based in Newtown, Pennsylvania, focuses on neurological wellness and went public on June 27, 2014. Their product, PoNS, is a non-implantable device that treats gait and balance deficits.
HSDT has been in the news recently: Helius Medical Technologies, Inc. (HSDT) experienced a surge in after-hours trading following the announcement of a $175 million acquisition of Solana (SOL/USD). The company also reported a 15% increase in profits and revenue for the last quarter, driven by strong demand and successful product launches in their technology division.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
